Marco Corniola

Dr. Marco Corniola

Department of Clinical Neurosciences, Division of Neurosurgery, Rennes University Hospitals, 2, Rue Henri Le Guilloux, 35000 Rennes, France
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2016 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MCMarco Corniola
Marco Corniola
MSM. N. Stienen
M. N. Stienen
HJH. Joswig
H. Joswig
NSN. R. Smoll
N. R. Smoll
KSK. Schaller
K. Schaller
OGO. P. Gautschi
O. P. Gautschi

21 January 2022 in Brain and Spine
Verified
Journal Article
Open access
MCMarco Corniola
Marco Corniola
PRPierre-Hugues Roche
Pierre-Hugues Roche
MBMichaël Bruneau
Michaël Bruneau
LCLuigi M. Cavallo
Luigi M. Cavallo
RDRoy T. Daniel
Roy T. Daniel
Torstein R. MelingTorstein R. Meling
Torstein R. Meling
The evolution of cavernous sinus meningiomas (CSMs) might be unpredictable and the efficacy of their treatments is challenging due to their indolent evolution, variations and fluctuations of symptoms, heterogeneity of classifications and lack of randomized controlled trials. Here, a dedicated task force provides a consensus statement on the overall management of CSMs. To determine the best overall management of CSMs, depending on their clinical presentation, size, and evolution as well as patient characteristics. Using the PRISMA 2020 guidelines, we included literature from January 2000 to December 2020. A total of 400 abstracts and 77 titles were kept for full-paper screening. The task force formulated 8 recommendations (Level C evidence). CSMs should be managed by a highly specialized multidisciplinary team. The initial evaluation of patients includes clinical, ophthalmological, endocrinological and radiological assessment. Treatment of CSM should involve experienced skull-base neurosurgeons or neuro-radiosurgeons, radiation oncologists, radiologists, ophthalmologists, and endocrinologists. Radiosurgery is preferred as first-line treatment in small, enclosed, pauci-symptomatic lesions/in elderly patients, while large CSMs not amenable to resection or WHO grade II-III are candidates for radiotherapy. Microsurgery is an option in aggressive/rapidly progressing lesions in young patients presenting with oculomotor/visual/endocrinological impairment. Whenever surgery is offered, open cranial approaches are the current standard. There is limited experience reported about endoscopic endonasal approach for CSMs and the main indication is decompression of the cavernous sinus to improve symptoms. Whenever surgery is indicated, the current trend is to offer decompression followed by radiosurgery.

1 August 2014 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
OGO.P. Gautschi
O.P. Gautschi
MPM. Payer
M. Payer
MCMarco Corniola
Marco Corniola
NSN.R. Smoll
N.R. Smoll
KSK. Schaller
K. Schaller
ETE. Tessitore
E. Tessitore

8 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MCMarco Corniola
Marco Corniola
JLJean-Michel Lemée
Jean-Michel Lemée
Torstein R. MelingTorstein R. Meling
Torstein R. Meling
Atypical or malignant transformation (AT/MT) has been described in WHO grade I meningiomas. Our aim was to identify predictive factors of AT/MT at recurrence. A total of N = 15 WHO grade increases were observed in N = 13 patients (0.96% of the study population, risk of transformation of 0.12% per patient-year follow-up). Patients with and without progression at recurrence were similar regarding age, gender distribution, skull-base location, bone infiltration, and Simpson grades. Recurrence-free survival was lower in patients with transformation (5 ± 4.06 years versus 7.3 ± 5.4 years; p = 0.03). Among patient age, gender, skull base location, extent of resection or post-operative RT, no predictor of AT/MT was identified, despite a follow-up of 10,524 patient-years. The annual risk of transformation of WHO grade I meningiomas was 0.12% per patient-year follow-up. Despite the important number of patients included and their extended follow-up, we did not identify any risk factor for transformation. A total of 1,352 patients with surgically managed WHO grade I meningioma from a mixed retro-and prospective database with mean follow-up of 9.2 years ± 5.7 years (0.3–20.9 years) were reviewed. Recurring tumors at the site of initial surgery were considered as recurrence.

18 August 2022 in Cancers
Verified
Journal Article
Open access
PDF file
MCMarco Corniola
Marco Corniola
Torstein R. MelingTorstein R. Meling
Torstein R. Meling
Background: While meningiomas often recur over time, the natural history of repeated recurrences and their management are not well described. Should recurrence occur, repeat surgery and/or use of adjuvant therapeutic options may be necessary. Here, we summarize current practice when it comes to meningioma recurrence after initial surgical management. Methods: A total of N = 89 articles were screened. N = 41 articles met the inclusion criteria and N = 16 articles failed to assess management of meningioma recurrence. Finally, N = 24 articles were included in our review. Results: The articles were distributed as follows: studies on chemotherapy (N = 14), radiotherapy, protontherapy, and stereotaxic radiosurgery (N = 6), boron-neutron capture therapy (N = 2) and surgery (N = 3). No study seems to provide serious alternatives to surgery in terms of progression-free and overall survival. Recurrence can occur long after the initial surgery and also affects WHO grade 1 meningiomas, even after initial gross total resection at first surgery, emphasizing the need for a long-term and comprehensive follow-up. Conclusions: Surgery still seems to be the state-of-the-art management when it comes to meningioma recurrence, since none of the non-surgical alternatives show promising results in terms of progression-free and overall survival.

11 March 2019 in Acta Neurochirurgica
Verified
Journal Article
Closed access
PDF file
MCMarco Corniola
Marco Corniola
JLJean-Michel Lemée
Jean-Michel Lemée
MBMichele Da Broi
Michele Da Broi
HJHolger Joswig
Holger Joswig
KSKarl Schaller
Karl Schaller
Torstein R. MelingTorstein R. Meling
Torstein R. Meling